Literature DB >> 14586040

Spotting latent infection: the path to better tuberculosis control.

A Lalvani.   

Abstract

Entities:  

Mesh:

Year:  2003        PMID: 14586040      PMCID: PMC1746498          DOI: 10.1136/thorax.58.11.916

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  16 in total

1.  An in-house RD1-based enzyme-linked immunospot-gamma interferon assay instead of the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection.

Authors:  Luigi Codecasa; Paola Mantegani; Laura Galli; Adriano Lazzarin; Paolo Scarpellini; Claudio Fortis
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

2.  Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice.

Authors:  T Meier; H-P Eulenbruch; P Wrighton-Smith; G Enders; T Regnath
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-08       Impact factor: 3.267

3.  The new tuberculosis: raised awareness of tuberculosis is vital in general practice.

Authors:  Chris Griffiths; Adrian Martineau
Journal:  Br J Gen Pract       Date:  2007-02       Impact factor: 5.386

4.  Evaluation of an interferon gamma assay in the diagnosis of latent tuberculosis infection in patients with rheumatoid arthritis.

Authors:  Cláudia Diniz Lopes Marques; Ângela Luzia Branco Pinto Duarte; Virginia Maria Barros de Lorena; Joelma Rodrigues Souza; Wayner Vieira Souza; Yara de Miranda Gomes; Eduardo Maia Freese de Carvalho
Journal:  Rheumatol Int       Date:  2009-11       Impact factor: 2.631

5.  Comparison of an in-house and a commercial RD1-based ELISPOT-IFN-gamma assay for the diagnosis of Mycobacterium tuberculosis infection.

Authors:  Paola Mantegani; Federica Piana; Luigi Codecasa; Laura Galli; Paolo Scarpellini; Adriano Lazzarin; Daniela Cirillo; Claudio Fortis
Journal:  Clin Med Res       Date:  2006-12

6.  T-SPOT.TB: an in vitro diagnostic assay measuring T-cell reaction to Mycobacterium tuberculosis-specific antigens.

Authors:  Antona J Wagstaff; Jean-Pierre Zellweger
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

7.  Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children.

Authors:  T G Connell; N Curtis; S C Ranganathan; J P Buttery
Journal:  Thorax       Date:  2006-04-06       Impact factor: 9.139

Review 8.  Advances in the diagnosis and treatment of tuberculosis.

Authors:  Payam Nahid; Madhukar Pai; Philip C Hopewell
Journal:  Proc Am Thorac Soc       Date:  2006

9.  Undocumented migrants in Switzerland: geographical origin versus legal status as risk factor for tuberculosis.

Authors:  H Wolff; J P Janssens; P Bodenmann; A Meynard; C Delhumeau; T Rochat; P Sudre; M C Costanza; J M Gaspoz; A Morabia
Journal:  J Immigr Minor Health       Date:  2010-02

10.  Comparison of an ESAT-6/CFP-10 peptide-based enzyme-linked immunospot assay to a tuberculin skin test for screening of a population at moderate risk of contracting tuberculosis.

Authors:  Esmaeil Porsa; Lee Cheng; Edward A Graviss
Journal:  Clin Vaccine Immunol       Date:  2007-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.